Nektar Therapeutics
(NASDAQ) NKTR
Nektar Therapeutics Financials at a Glance
Market Cap
$2.39B
Revenue (TTM)
$55.63M
Net Income (TTM)
$158.10M
EPS (TTM)
$-8.42
P/E Ratio
-8.39
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Price
$70.56
Volume
68,736
Open
$73.00
Price
$70.56
Volume
68,736
Open
$73.00
Previous Close
$70.56
Daily Range
$69.40 - $73.11
52-Week Range
$7.99 - $109.00
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Price
$70.56
Volume
68,736
Open
$73.00
Previous Close
$70.56
Daily Range
$69.40 - $73.11
52-Week Range
$7.99 - $109.00
NKTR News
NKTR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nektar Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
63
CEO
Howard W. Robin
Website
www.nektar.comHeadquarters
San Francisco, CA 94158, US
NKTR Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-2%
Net Income Margin
-3%
Return on Equity
-54%
Return on Capital
-18%
Return on Assets
-21%
Earnings Yield
-11.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.39B
Shares Outstanding
33.79M
Volume
68.74K
Avg. Volume
1.03M
Financials (TTM)
Gross Profit
$55.23M
Operating Income
$130.77M
EBITDA
$129.74M
Operating Cash Flow
$208.51M
Capital Expenditure
$171.00K
Free Cash Flow
$208.68M
Cash & ST Invst.
$245.75M
Total Debt
$148.91M
Nektar Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.86M
+3.8%
Gross Profit
$10.71M
+2.4%
Gross Margin
98.61%
N/A
Market Cap
$2.39B
N/A
Market Cap/Employee
$39.11M
N/A
Employees
61
N/A
Net Income
$44.90M
+11.7%
EBITDA
$38.11M
+7.0%
Quarterly Fundamentals
Net Cash
$425.17M
+259.4%
Accounts Receivable
$3.60M
+110.0%
Inventory
$0.00
N/A
Long Term Debt
$120.90M
+54.0%
Short Term Debt
$22.53M
+3.2%
Return on Assets
-20.71%
N/A
Return on Invested Capital
-17.73%
N/A
Free Cash Flow
$44.32M
+9.7%
Operating Cash Flow
$44.30M
+9.7%